Showing results (1-10 of 41) with videos related to
Sort By:
Pageof 5
Journal of Pain Research|November 15, 2018
Oral methylnaltrexone is efficacious and well tolerated for the treatment of opioid-induced constipation in patients with chronic noncancer pain receiving concomitant methadoneLynn R Webster, Robert J IsraelFrontiers in Bioscience (Landmark Edition)|January 7, 2014
Antibody-drug conjugates targeting prostate-specific membrane antigenWilliam C Olson, Robert J IsraelJournal of Pain Research|August 28, 2018
Oral methylnaltrexone does not negatively impact analgesia in patients with opioid-induced constipation and chronic noncancer painLynn R Webster, Robert J IsraelExpert Opinion on Investigational Drugs|April 26, 2006
Methylnaltrexone, a novel peripheral opioid receptor antagonist for the treatment of opioid side effectsChun-Su Yuan, Robert J IsraelJournal of the American Academy of Dermatology|June 9, 2019
Immunogenicity and skin clearance recapture in clinical studies of brodalumabJerry Bagel, Mark Lebwohl, Robert J Israel, et al.Clinical and Translational Science|November 3, 2022
Ribavirin aerosol in hospitalized adults with respiratory distress and COVID-19: An open-label trialGaryfallia Poulakou, Maxime Barakat, Robert J Israel, et al.F1000Research|July 13, 2023
Attrition of methylnaltrexone treatment-emergent adverse events in patients with chronic noncancer pain and opioid-induced constipation: a post hoc pooled analysis of two clinical trialsNeel Mehta, Neal E Slatkin, Robert J Israel, et al.The Journal of Emergency Medicine|December 11, 2021
First-Dose Efficacy of Methylnaltrexone in Patients with Severe Medical Illness and Opioid-Induced Constipation: A Pooled AnalysisW Frank Peacock, Neal E Slatkin, Robert J Israel, et al.Journal of Pain Research|January 8, 2019
Safety of oral methylnaltrexone for opioid-induced constipation in patients with chronic noncancer painRichard L Rauck, Neal E Slatkin, Nancy Stambler, et al.American Journal of Clinical Dermatology|March 25, 2020
Malignancy Rates in Brodalumab Clinical Studies for PsoriasisAlice Gottlieb, Mark Lebwohl, Clive Liu, et al.Pageof 5